- Home
- THM vs MGTX Comparison
THM vs MGTX Comparison
Compare THM & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | THM | MGTX |
|---|---|---|
| Founded | 1978 | 2015 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 685.5M | 610.1M |
| IPO Year | 2002 | 2018 |
Fundamental Metrics
Financial Performance| Metric | THM | MGTX |
|---|---|---|
| Price | $2.52 | $9.26 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $24.57 |
| AVG Volume (30 Days) | 988.0K | ★ 1.1M |
| Earning Date | 05-08-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 33.02 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $81,391,000.00 |
| Revenue This Year | N/A | $141.38 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 144.57 |
| 52 Week Low | $0.61 | $5.02 |
| 52 Week High | $3.65 | $11.85 |
Technical Indicators
Market Signals| Indicator | THM | MGTX |
|---|---|---|
| Relative Strength Index (RSI) | 50.56 | 50.53 |
| Support Level | $2.17 | $7.21 |
| Resistance Level | $3.63 | $9.65 |
| Average True Range (ATR) | 0.15 | 0.76 |
| MACD | 0.02 | -0.06 |
| Stochastic Oscillator | 50.96 | 16.45 |
Price Performance
Historical ComparisonAbout THM International Tower Hill Mines Ltd. (Canada)
International Tower Hill Mines Ltd is a mining company. It is engaged in the acquisition, exploration, and development of mineral properties. The company holds interests in an exploration project, namely the Livengood Gold Project. It is located in the northwest of Fairbanks, Alaska, in the Tolovana mining district within the Tintina gold belt. The project property consists of land leased from the Alaska Mental Health Trust, several smaller private mineral leases, Alaska state mining claims purchased or located by the company, and the patented ground held by the company.
About MGTX MeiraGTx Holdings plc
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.